DFE Pharma’s CEO Martti Hedman discusses the partnership established by DFE Pharma, Harro Höfliger, and Sterling, in the field of dry powder inhalation.
Includes a multimillion-dollar investment to expand Corning’s Valor Glass technology to enable advanced injectable drug packaging and delivery systems.
Enhances the company's experience in producing lipids, one of the critical components for the formulation of mRNA therapeutics including Covid-19 vaccines.
This webcast will outline the typical steps Oakwood Labs takes during post-feasibility, scale-up, technology transfer, and Phase I clinical batch production.